Lunar International Science Coordination/Calibration Targets

A new era of international lunar exploration has begun and will expand over the next four years with data acquired from at least four sophisticated remote sensing missions: KAGUYA (SELENE) [Japan], Chang'E [China], Chandrayaan-l [India], and LRO [United States]. It is recognized that this combined activity at the Moon with modern sophisticated sensors wi II provide unprecedented new information about the Moon and will dramatically improve our understanding of Earth's nearest neighbor. It is anticipated that the blooming of scientific exploration of the Moon by nations involved in space activities will seed and foster peaceful international coordination and cooperation that will benefit all. Summarized here are eight Lunar International Science Coordination/Calibration Targets (L-ISCT) that are intended to a) allow cross-calibration of diverse multi-national instruments and b) provide a focus for training young scientists about a range of lunar science issues. The targets, discussed at several scientific forums, were selected for coordinated science and instrument calibration of orbital data. All instrument teams are encouraged to participate in a coordinated activity of early-release data that will improve calibration and validation of data across independent and diverse instruments

Strong bulk plasma acceleration in Earth's magnetosheath: A magnetic slingshot effect?

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/94743/1/grl23179.pd

Immunological aspects in chronic lymphocytic leukemia (CLL) development

Chronic lymphocytic leukemia (CLL) is unique among B cell malignancies in that the malignant clones can be featured either somatically mutated or unmutated IGVH genes. CLL cells that express unmutated immunoglobulin variable domains likely underwent final development prior to their entry into the germinal center, whereas those that express mutated variable domains likely transited through the germinal center and then underwent final development. Regardless, the cellular origin of CLL remains unknown. The aim of this review is to summarize immunological aspects involved in this process and to provide insights about the complex biology and pathogenesis of this disease. We propose a mechanistic hypothesis to explain the origin of B-CLL clones into our current picture of normal B cell development. In particular, we suggest that unmutated CLL arises from normal B cells with self-reactivity for apoptotic bodies that have undergone receptor editing, CD5 expression, and anergic processes in the bone marrow. Similarly, mutated CLL would arise from cells that, while acquiring self-reactivity for autoantigens—including apoptotic bodies—in germinal centers, are also still subject to tolerization mechanisms, including receptor editing and anergy. We believe that CLL is a proliferation of B lymphocytes selected during clonal expansion through multiple encounters with (auto)antigens, despite the fact that they differ in their state of activation and maturation. Autoantigens and microbial pathogens activate BCR signaling and promote tolerogenic mechanisms such as receptor editing/revision, anergy, CD5+ expression, and somatic hypermutation in CLL B cells. The result of these tolerogenic mechanisms is the survival of CLL B cell clones with similar surface markers and homogeneous gene expression signatures. We suggest that both immunophenotypic surface markers and homogenous gene expression might represent the evidence of several attempts to re-educate self-reactive B cells